Navigation Links
ATCC to Develop Custom Cell Lines for The Michael J. Fox Foundation for Parkinson's Research

MANASSAS, Va., Oct. 8, 2015 /PRNewswire/ -- ATCC, the premier global biological materials resource and standards organization, announces today that it has been selected by The Michael J. Fox Foundation for Parkinson's Research (MJFF) to provide vital cell lines to academic, pharmaceutical, and biotechnology organizations committed to speed a cure for Parkinson's disease. 

Parkinson's disease is a chronic, degenerative neurological disorder that affects one in 100 people over age 60. While the average age at onset is 60, people have been diagnosed as young as 18. Recent research indicates that at least 1 million people in the United States, and more than 5 million worldwide, have Parkinson's disease.

Under the terms of the agreement, ATCC will provide services and products to the global scientific community that is working to address this challenging disease.  Specifically ATCC will provide cell line authentication, mycoplasma testing, and repository management services.  ATCC will also produce and validate custom master cell banks (MCBs) from macrophage cell lines provided by MJFF, including wild-type LRRK2, LRRK2 knockout, and human LRRK2 T1348N (GTPase-dead) knockin.

"At our core, ATCC is about contributing to breakthrough scientific discoveries through the provision of high quality biological products and services.  We are honored to partner with The Michael J. Fox Foundation to accelerate breakthroughs in Parkinson's disease research," stated Raymond Cypess, DVM, Ph.D., CEO at ATCC.  "As the premier biological resource center that global researchers have relied on for 90 years, ATCC has been privileged to work with outstanding organizations, such as The Michael J. Fox Foundation, and we look forward to partnering with additional foundations."

Terina Martinez, Ph.D., associate director of research programs at MJFF, said, "These cell lines are important tools for our efforts to advance understanding of Parkinson's disease and further drug development toward new therapies for the millions living with this disease. We're pleased to be working toward these goals with ATCC, a well-regarded organization with the capabilities and track record to help us serve the Parkinson's research community."

This special cell line collection will be established by the end of the first quarter of 2016 and will be available at

About ATCC
ATCC collaborates with and supports the scientific community with industry-standard products and innovative solutions. With the world's largest and most diverse collection of human, animal, and plant cell lines, as well as molecular genomic tools, microorganisms, and biological products, ATCC is a trusted biological resource for the worldwide research community. Together, the people of ATCC share in its mission to acquire, authenticate, preserve, develop, and distribute biological materials and information for the advancement of scientific knowledge. Founded in 1925, ATCC is a non-profit organization with headquarters in Manassas, VA. Discover more at

About The Michael J. Fox Foundation for Parkinson's Research
As the world's largest nonprofit funder of Parkinson's research, The Michael J. Fox Foundation is dedicated to accelerating a cure for Parkinson's disease and improved therapies for those living with the condition today. The Foundation pursues its goals through an aggressively funded, highly targeted research program coupled with active global engagement of scientists, Parkinson's patients, business leaders, clinical trial participants, donors and volunteers. In addition to funding more than $450 million in research to date, the Foundation has fundamentally altered the trajectory of progress toward a cure. Operating at the hub of worldwide Parkinson's research, the Foundation forges groundbreaking collaborations with industry leaders, academic scientists and government research funders; increases the flow of participants into Parkinson's disease clinical trials with its online tool, Fox Trial Finder; promotes Parkinson's awareness through high-profile advocacy, events and outreach; and coordinates the grassroots involvement of thousands of Team Fox members around the world.

Company contact

Renee Randall  
Tel: (703) 365-2773     

Logo -

Copyright©2015 PR Newswire.
All rights reserved

Related biology technology :

1. Infinity to Provide Update on Duvelisib and Immuno-Oncology Development Candidate IPI-549 During 2015 Research and Development Day
2. Regulus to Present Additional Preclinical Data Supporting RG-012 as a Novel microRNA Therapeutic in Development for Alport Syndrome at ASNs Kidney Week 2015
3. Matt Bellina, Sarah Coglianese, Bobby Forster, Beth Hebron, Maureen Ramirez/Team Godfather & Jay Smith to Receive Leadership Awards from ALS Therapy Development Institute
4. Regis Attends CPhI: The #1 Pharma Sourcing Event in Drug Development
5. ProPhase and YPrime Partner to Develop eCOA and other Digital Products Designed to Enhance Clinical Trial Outcomes
6. Dmitry Medvedev Will Discuss Innovation Development in Russia With Heads of International Technological Corporations
7. FDA Office of Orphan Products Development Awards Rhythm $1 Million Grant to Support Phase 2 Study of Setmelanotide in Prader-Willi Syndrome
8. HealthWell Foundation Strengthens Senior Management with New Chief Business Development Officer
9. FDA Office Of Orphan Products Development Designates Udenafil As An Orphan Drug For Use In Patients With A Single Functional Ventricle That Have Undergone Fontan Surgical Palliation
10. AxioMx Announces Receipt of SBIR Grant for DNA-Protein Complex Antigen Development
11. iLab Solutions Hires Gerard Gibbs, Director of Business Development, Asia Pacific
Post Your Comments:
(Date:10/12/2017)... ... October 12, 2017 , ... AMRI, a global contract ... to improve patient outcomes and quality of life, will now be offering its ... attributed to new regulatory requirements for all new drug products, including the finalization ...
(Date:10/11/2017)... Charlotte, N.C. (PRWEB) , ... October 11, 2017 ... ... ARCS® Foundation President Andi Purple announced Dr. Suneel I. Sheikh, the ... Laboratories ( ASTER Labs ), Inc. has been selected for membership in ...
(Date:10/11/2017)... , ... October 11, 2017 , ... Personal eye wash is a basic first aid ... at a time. So which eye do you rinse first if a dangerous substance enters ... Plum Duo Eye Wash with its unique dual eye piece. , “Whether its dirt ...
(Date:10/11/2017)... ... October 11, 2017 , ... Proscia Inc ... hosting a Webinar titled, “Pathology is going digital. Is your lab ready?” with ... adoption best practices and how Proscia improves lab economics and realizes an increase ...
Breaking Biology Technology:
(Date:4/4/2017)...   EyeLock LLC , a leader of iris-based ... Patent and Trademark Office (USPTO) has issued U.S. Patent ... an iris image with a face image acquired in ... 45 th issued patent. "The ... the multi-modal biometric capabilities that have recently come to ...
(Date:3/30/2017)... 2017 Trends, opportunities and forecast in this ... technology (fingerprint, AFIS, iris recognition, facial recognition, hand geometry, ... end use industry (government and law enforcement, commercial and ... and others), and by region ( North America ... Asia Pacific , and the Rest of the ...
(Date:3/24/2017)... The Controller General of Immigration from Maldives Mr. ... have received the prestigious international IAIR Award for the most innovative ... ... Maldives Immigration ... Algeen (small picture on the right) have received the IAIR award for ...
Breaking Biology News(10 mins):